Magnetic Resonance Spectroscopy: An in Vivo Molecular Imaging Biomarker for Parkinson’s Disease?

BioMed Research International - United States
doi 10.1155/2014/519816
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

The Contribution of Magnetic Resonance Spectroscopy as Biomarker in Alzheimer’s Disease

Journal of Biomedical Graphics and Computing
2012English

Magnetic Resonance Spectroscopy VI. Magnetic Resonance Imaging

Journal of the Spectroscopical Society of Japan
2006English

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias

Journal of Geriatric Psychiatry and Neurology
PsychiatryGerontologyGeriatricsMental HealthNeurology
2001English

Atherosclerosis Endothelial Activation Quantification in Vivo With Fluorine Magnetic Resonance Imaging and Spectroscopy

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2014English

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?

PLoS ONE
Multidisciplinary
2016English

Magnetic Resonance Imaging in Huntington’s Disease

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Hyperpolarised Magnetic Resonance for in Vivo Real-Time Metabolic Imaging

Heart
Cardiovascular MedicineCardiology
2018English

Magnetic Resonance Imaging in Fabry's Disease.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1988English

Wilson’s Disease in Brain Magnetic Resonance Spectroscopy

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy